KLRK1 and cervical carcinoma: Expression of the activation receptors NKp30, NKp46, and NKG2D, but not NKp80 and 2B4 have been reported to be reduced in patients with cervical cancer and with precursor lesions when compared to healthy controls (Garcia-Iglesias et al., 2009).